Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Projections for the CAGR of the Porcine Vaccine Market Size From 2025 to 2034?

The market size for porcine vaccines has been expanding significantly in the last few years. Its progression from $1.89 billion in 2024 to $2.05 billion in 2025, with a compound annual growth rate (CAGR) of 8.5%, is quite impressive. The factors contributing to this development during the historical period include disease outbreaks and the actions taken to control them, a worldwide rise in pork intake, the fortification of pig farming, government schemes aimed at disease control, as well as initiatives to increase awareness and education.

The market for porcine vaccines is predicted to experience a hefty expansion in the upcoming years, inflating to $2.94 billion by 2029 with a compound annual growth rate (CAGR) of 9.4%. The surge during the projection period can be credited to the worldwide growth of pig farming, increasing disease threats, strict regulations and adherence, advances in vaccine research, international commerce, and disease risk reduction. Key trends during this period encompass vaccine customization for regional challenges, the integration of biotechnology with vaccine creation, increased alarm over zoonotic diseases, the use of genomic methods in vaccine design, and escalating investment in research and development.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9111&type=smp

What External and Internal Drivers Are Contributing to the Growth of thePorcine Vaccine Market?

The growth of the porcine vaccine market is set to be propelled by the escalating incidence of swine disease. A common respiratory condition affecting pigs, swine flu (swine influenza) is typically triggered by the type A influenza virus, which is known to prompt frequent outbreaks among pigs. By introducing porcine vaccines to pigs, their immune systems respond and remember the pathogenic agent by triggering an immunogenic reaction. These vaccinations equip the pigs’ immune systems to resist pathogens, thereby averting disease by invoking an anamnestic response upon the next encounter with that same pathogen. As an example, the UK Government cited an information website based in the UK in September 2024, warning that a potential African swine fever (ASF) outbreak could significantly harm the UK’s pig sector, valued at £8 billion, and its annual £600 million exports of pork and related products. They projected the likely financial repercussion of such an outbreak could be anywhere between £10 million-£100 million. Thus, the increasing prevalence of swine diseases is spurring the growth of the porcine vaccine market.

What Segment Types Define the Porcine Vaccine Market Structure?

The porcine vaccine market covered in this report is segmented –

1) By Technology: Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, DNA Vaccines

2) By Disease Indication: Diarrhea, Swine Influenza, Arthritis, Bordetella Rhinitis, Porcine Reproductive and Respiratory Virus (PRRSV), Porcine Circovirus Associated Disease (PCVAD), Other Disease Indications

3) By End User: Veterinary Hospitals, Hog or Pig Production Farm

Subsegments:

1) By Inactivated Vaccines: Whole Virus Inactivated Vaccines, Subunit Inactivated Vaccines

2) By Live Attenuated Vaccines: Live Modified Vaccines, Live Virulent Vaccines

3) By Toxoid Vaccines: Inactivated Toxins

4) By Recombinant Vaccines: Recombinant Vector Vaccines, Subunit Recombinant Vaccines

5) By Conjugate Vaccines: Polysaccharide Conjugate Vaccines

6) By DNA Vaccines: Plasmid DNA Vaccines

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=9111&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Porcine Vaccine Market?

North America is the largest region in the porcine vaccine market in 2024. The regions covered in the porcine vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Long-Term Trends Are Transforming the Competitive Landscape of the Porcine Vaccine Market?

Leading players in the porcine vaccine industry are adopting strategic collaborations to bolster their research and developmental competencies and fortify their competitive stance in the rapidly advancing animal health sector. This partnership leverages the capabilities of TVG in vaccine technology and the prowess of Pirbright in African swine fever (ASF) research. The primary motive of this collaborative exercise is to streamline the process of vaccine development and discover innovative methods with the potential to significantly enhance swine health. In the instance of May 2024, The Pirbright Institute and The Vaccine Group (TVG), both based in the UK, allied to engender a vaccine for African swine fever (ASF). The objective of this research is to create vaccines for the prevention of ASF by employing bovine herpesvirus 4 (BoHV-4) as a base. This technique exploits the most recent discoveries in ASF vaccine research and pig immunology to construct more effective vaccines. The UK’s Department for Environment, Food and Rural Affairs (Defra) and the Biotechnology and Biological Sciences Research Council (BBSRC) financially supports this endeavour.

View the full report here:

https://www.thebusinessresearchcompany.com/report/porcine-vaccine-global-market-report

What Is the Definition of the Porcine Vaccine Market?

Porcine vaccines are a medical and pharmaceutical treatment that improves the health of pigs by shielding them from different bacteria, viruses, and other infections. It is used to increase the efficacy of protecting pigs from harmful ailments while increasing the output of top-notch meat for human consumption.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9111

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model